Diagnosis
Drs. C. Edward Evans (McMaster University, Hamilton), R. Brian Haynes (chair; McMaster University), Yves Lacourcière (Laval University, Quebec), Frans H.H. Leenen (University of Ottawa), Alexander G. Logan (University of Toronto), Simon W. Rabkin (University of British Columbia, Vancouver) and Noël Wright (McMaster University)
Pharmacotherapy
Drs. Ellen D. Burgess (University of Calgary), Jean Cusson (University of Montreal), Ross D. Feldman (University of Western Ontario, London), Lawrence A. Leiter (University of Toronto), Martin G. Myers (University of Toronto) and Richard I. Ogilvie (chair; University of Toronto)
Elderly
Drs. J. George Fodor (Memorial University of Newfoundland, St. John's), Cyril I. Gryfe (University of Toronto), Christopher Patterson (McMaster University), Richard A. Reeves (chair; University of Toronto) and J. David Spence (University of Western Ontario)
Diabetes
Drs. Jean-Louis Chiasson (University of Montreal), Keith G. Dawson (University of British Columbia), Pavel Hamet (chair; University of Montreal), John K. McKenzie (University of Manitoba, Winnipeg) and Stuart A. Ross (University of Calgary)
Observers
Committee I -- Diagnosis and Pharmacotherapy
Manuel Cardoso (Merck Frosst Canada Inc.), Monique Giguère (Rhône Poulenc Rorer), Wendy Hill (Knoll Pharmaceuticals Canada), Réjean Lemay (Servier Canada Inc.), Pierre Roland (Abbottt Laboratories, Limited), Hélène Toupin (Shering Canada Inc.), Guy Tremblay (medical director, Association of Medical Directors of the Life Insurance Industry), Claude Vezeau (G.D. Searle and Co. of Canada, Limited) and Chris Yardley (Sandoz Canada Inc.)
Committee II -- Elderly and Diabetes
André Boulet (Nordic Merrell Dow), François Charette (Bristol Myers Squibb), Pierre Dessain (Pfizer Canada Inc.), Gale Larocque (ICI Pharma), Milos Nadasdi (Wyeth Ltd.), Myron Pyzyk (Hoffmann-La Rohe Limited) Corey Toal (Miles Canada Inc.), Carley Vint-Reed (Astra Pharma Inc.) and Daniel Yannicelli (Parke-Davis)